 |
PDBsum entry 1wdy
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Crystal structure of ribonuclease
|
|
Structure:
|
 |
2-5a-dependent ribonuclease. Chain: a. Fragment: residues 21-305. Synonym: 2-5a-dependent rnase, ribonuclease l, rnase l, ribonuclease 4. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.80Å
|
R-factor:
|
0.203
|
R-free:
|
0.230
|
|
|
Authors:
|
 |
N.Tanaka,M.Nakanishi,Y.Kusakabe,Y.Goto,Y.Kitade,K.T.Nakamura
|
Key ref:
|
 |
N.Tanaka
et al.
(2004).
Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
EMBO J,
23,
3929-3938.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
19-May-04
|
Release date:
|
05-Oct-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q05823
(RN5A_HUMAN) -
2-5A-dependent ribonuclease from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
741 a.a.
285 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
EMBO J
23:3929-3938
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
|
|
N.Tanaka,
M.Nakanishi,
Y.Kusakabe,
Y.Goto,
Y.Kitade,
K.T.Nakamura.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
An interferon-induced endoribonuclease, ribonuclease L (RNase L), is implicated
in both the molecular mechanism of action of interferon and the fundamental
control of RNA stability in mammalian cells. RNase L is catalytically active
only after binding to an unusual activator molecule containing a
5'-phosphorylated 2',5'-linked oligoadenylate (2-5A), in the N-terminal half.
Here, we report the crystal structure of the N-terminal ankyrin repeat domain
(ANK) of human RNase L complexed with the activator 2-5A. This is the first
structural view of an ankyrin repeat structure directly interacting with a
nucleic acid, rather than with a protein. The ANK domain folds into eight
ankyrin repeat elements and forms an extended curved structure with a concave
surface. The 2-5A molecule is accommodated at a concave site and directly
interacts with ankyrin repeats 2-4. Interestingly, two structurally equivalent
2-5A binding motifs are found at repeats 2 and 4. The structural basis for 2-5A
recognition by ANK is essential for designing stable 2-5As with a high
likelihood of activating RNase L.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Figure 1 Crystal structure of ANK complexed with 2-5A. (A)
Structural and functional domains of RNase L. Ankyrin repeats
are shown starting with blue at repeat 1 and ending with red at
repeat 8. (B) Structure of the predominant trimeric species of
2-5A ((pp)p(A2'p5')[2]A) (Kerr and Brown, 1978). (C, D) Surface
(top) and ribbon (bottom) representations of the ANK/2-5A
complex. Ankyrin repeats (R1 -R8) are shown as in (A). The bound
2-5A molecule is shown as a ball-and-stick model. The view in
(D) was obtained by rotating the view in (C) by 90°.
|
 |
Figure 3.
Figure 3 Recognition of 2-5A by ANK. (A) Stereodiagram showing
the mode of 2-5A binding to ANK. The carbon atoms of ANK are
colored as in Figure 1, and those of the bound 2-5A molecule are
shown in white. Possible hydrogen bonds or salt bridges are
indicated by dashed lines, and distances (in Å) are given. The
refined model is superimposed on the weighted 2|F[o]| -|F[c]|
map (1.5 ,
yellow) and the |F[o]| -|F[c]| omit map of 2-5A (4.5 ,
orange), calculated at 1.8 Å resolution. Bound water molecules
are shown as spheres (cyan). (B, C) Recognition of the first and
third AMP moieties of 2-5A by repeats 4 and 2, respectively, of
ANK.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
EMBO J
(2004,
23,
3929-3938)
copyright 2004.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.D.Licchesi,
J.Mieszczanek,
T.E.Mevissen,
T.J.Rutherford,
M.Akutsu,
S.Virdee,
F.El Oualid,
J.W.Chin,
H.Ovaa,
M.Bienz,
and
D.Komander
(2012).
An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains.
|
| |
Nat Struct Mol Biol,
19,
62-71.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Chakrabarti,
B.K.Jha,
and
R.H.Silverman
(2011).
New insights into the role of RNase L in innate immunity.
|
| |
J Interferon Cytokine Res,
31,
49-57.
|
 |
|
|
|
|
 |
T.Shiraishi,
Y.Kitamura,
Y.Ueno,
and
Y.Kitade
(2011).
Synthesis of oligonucleotides possessing versatile probes for PET labelling and their rapid ligand-free click reaction.
|
| |
Chem Commun (Camb),
47,
2691-2693.
|
 |
|
|
|
|
 |
J.A.Zorn,
and
J.A.Wells
(2010).
Turning enzymes ON with small molecules.
|
| |
Nat Chem Biol,
6,
179-188.
|
 |
|
|
|
|
 |
W.M.Li,
T.Barnes,
and
C.H.Lee
(2010).
Endoribonucleases--enzymes gaining spotlight in mRNA metabolism.
|
| |
FEBS J,
277,
627-641.
|
 |
|
|
|
|
 |
B.E.Madsen,
E.M.Ramos,
M.Boulard,
K.Duda,
J.Overgaard,
M.Nordsmark,
C.Wiuf,
and
L.L.Hansen
(2008).
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
|
| |
PLoS ONE,
3,
e2492.
|
 |
|
|
|
|
 |
H.L.Townsend,
B.K.Jha,
J.Q.Han,
N.K.Maluf,
R.H.Silverman,
and
D.J.Barton
(2008).
A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.
|
| |
RNA,
14,
1026-1036.
|
 |
|
|
|
|
 |
R.Gaudet
(2008).
A primer on ankyrin repeat function in TRP channels and beyond.
|
| |
Mol Biosyst,
4,
372-379.
|
 |
|
|
|
|
 |
A.Wagner
(2007).
Rapid detection of positive selection in genes and genomes through variation clusters.
|
| |
Genetics,
176,
2451-2463.
|
 |
|
|
|
|
 |
C.Bisbal,
and
R.H.Silverman
(2007).
Diverse functions of RNase L and implications in pathology.
|
| |
Biochimie,
89,
789-798.
|
 |
|
|
|
|
 |
C.L.Washenberger,
J.Q.Han,
K.J.Kechris,
B.K.Jha,
R.H.Silverman,
and
D.J.Barton
(2007).
Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L.
|
| |
Virus Res,
130,
85-95.
|
 |
|
|
|
|
 |
C.S.Thakur,
B.K.Jha,
B.Dong,
J.Das Gupta,
K.M.Silverman,
H.Mao,
H.Sawai,
A.O.Nakamura,
A.K.Banerjee,
A.Gudkov,
and
R.H.Silverman
(2007).
Small-molecule activators of RNase L with broad-spectrum antiviral activity.
|
| |
Proc Natl Acad Sci U S A,
104,
9585-9590.
|
 |
|
|
|
|
 |
J.J.Rios,
A.A.Perelygin,
M.T.Long,
T.L.Lear,
A.A.Zharkikh,
M.A.Brinton,
and
D.L.Adelson
(2007).
Characterization of the equine 2'-5' oligoadenylate synthetase 1 (OAS1) and ribonuclease L (RNASEL) innate immunity genes.
|
| |
BMC Genomics,
8,
313.
|
 |
|
|
|
|
 |
J.Q.Han,
H.L.Townsend,
B.K.Jha,
J.M.Paranjape,
R.H.Silverman,
and
D.J.Barton
(2007).
A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.
|
| |
J Virol,
81,
5561-5572.
|
 |
|
|
|
|
 |
K.Morita,
M.Kaneko,
S.Obika,
T.Imanishi,
Y.Kitade,
and
M.Koizumi
(2007).
Biologically Stable 2-5A Analogues containing 3'-O,4'-C-bridged Adenosine as Potent RNase L Agonists.
|
| |
ChemMedChem,
2,
1703-1707.
|
 |
|
|
|
|
 |
N.Tanaka
(2007).
[Structural and functional studies on proteins as potential drug discovery targets]
|
| |
Yakugaku Zasshi,
127,
1673-1683.
|
 |
|
|
|
|
 |
R.H.Silverman
(2007).
Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.
|
| |
J Virol,
81,
12720-12729.
|
 |
|
|
|
|
 |
R.H.Silverman
(2007).
A scientific journey through the 2-5A/RNase L system.
|
| |
Cytokine Growth Factor Rev,
18,
381-388.
|
 |
|
|
|
|
 |
S.Chevaliez,
and
J.M.Pawlotsky
(2007).
Interferon-based therapy of hepatitis C.
|
| |
Adv Drug Deliv Rev,
59,
1222-1241.
|
 |
|
|
|
|
 |
H.Rennert,
C.Sadowl,
J.Edwards,
D.Bantly,
R.J.Molinaro,
A.Orr-Urtreger,
A.Bagg,
J.S.Moore,
and
R.H.Silverman
(2006).
An alternative spliced RNASEL variant in peripheral blood leukocytes.
|
| |
J Interferon Cytokine Res,
26,
820-826.
|
 |
|
|
|
|
 |
A.Zhou,
R.J.Molinaro,
K.Malathi,
and
R.H.Silverman
(2005).
Mapping of the human RNASEL promoter and expression in cancer and normal cells.
|
| |
J Interferon Cytokine Res,
25,
595-603.
|
 |
|
|
|
|
 |
M.Nakanishi,
N.Tanaka,
Y.Mizutani,
M.Mochizuki,
Y.Ueno,
K.T.Nakamura,
and
Y.Kitade
(2005).
Functional characterization of 2',5'-linked oligoadenylate binding determinant of human RNase L.
|
| |
J Biol Chem,
280,
41694-41699.
|
 |
|
|
|
|
 |
M.Nakanishi,
Y.Goto,
and
Y.Kitade
(2005).
2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
|
| |
Proteins,
60,
131-138.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |